Metabolic abnormalities and obesity’s impact on the risk for developing preeclampsia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 312, Issue 1, 2017, Pages R5-R12

  Spradley, Frank T ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; Endothelium; Gestational diabetes mellitus; Hypertension; Women s health

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; IMMUNOLOGIC FACTOR;

CARDIOVASCULAR FUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; ISCHEMIA; LIPID BLOOD LEVEL; MATERNAL HYPERTENSION; MATERNAL OBESITY; METABOLIC DISORDER; NONHUMAN; OBESITY; PLACENTAL ISCHEMIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULARIZATION; BLOOD; CAUSALITY; COMORBIDITY; EVIDENCE BASED MEDICINE; FEMALE; IMMUNOLOGY; META ANALYSIS; METABOLIC DISEASES; PRE-ECLAMPSIA; PREGNANCY;

BIOMARKERS; CAUSALITY; COMORBIDITY; CYTOKINES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; METABOLIC DISEASES; OBESITY; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 85008392686     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00440.2016     Document Type: Review

References (99)

1. Aasa KL, Zavan B, Luna RL, Wong PG, Ventura NM, Tse MY, Carmeliet P, Adams MA, Pang SC, Croy BA. Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice. Biol Reprod 92: 44, 2015. doi: 10.1095/biolreprod.114.124677.
2. Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab 6: 103–108, 2015. doi: 10.1177/2042018815577039.
3. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122: 1122–1131, 2013. doi: 10.1097/01.AOG.0000437382.03963.88.
4. Avagliano L, Marconi AM, Romagnoli S, Bulfamante GP. Abnormal spiral arteries modification in stillbirths: the role of maternal prepregnancy body mass index. J Matern Fetal Neonatal Med 25: 2789–2792, 2012. doi: 10.3109/14767058.2012.705395.
5. Aye IL, Rosario FJ, Powell TL, Jansson T. Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth. Proc Natl Acad Sci U S A 112: 12858–12863, 2015. doi: 10.1073/pnas.1515484112.
6. Benoit C, Zavecz J, Wang Y. Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas. Placenta 28: 498–504, 2007. doi: 10.1016/j.placenta.2006.09.002.
7. Burke SD, Barrette VF, David S, Khankin EV, Adams MA, Croy BA. Circulatory and renal consequences of pregnancy in diabetic NOD mice. Placenta 32: 949–955, 2011. doi: 10.1016/j.placenta.2011.09.018.
8. Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ; HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35: 780–786, 2012. doi: 10.2337/dc11-1790.
9. Cawyer CR, Horvat D, Leonard D, Allen SR, Jones RO, Zawieja DC, Kuehl TJ, Uddin MN. Hyperglycemia impairs cytotrophoblast function via stress signaling. Am J Obstet Gynecol 211: 541.e1–541.e8, 2014. doi: 10.1016/j.ajog.2014.04.033.
10. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29: 274–281, 2008. doi: 10.1016/j.placenta.2007.12.010.
11. Chen Q, Yin YX, Wei J, Tong M, Shen F, Zhao M, Chamley L. Increased expression of high mobility group box 1 (HMGB1) in the cytoplasm of placental syncytiotrophoblast from preeclamptic placentae. Cytokine 85: 30–36, 2016. doi: 10.1016/j.cyto.2016.06.001.
12. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 30: 2070–2076, 2007. doi: 10.2337/dc06-2559a.
13. Clark SL, Cotton DB, Lee W, Bishop C, Hill T, Southwick J, Pivarnik J, Spillman T, DeVore GR, Phelan J, Hankins GDV, Benedetti TJ, Tolley D. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 161: 1439–1442, 1989. doi: 10.1016/0002-9378 (89) 90900-9.
14. Cohen A, Lim KH, Lee Y, Rana S, Karumanchi SA, Brown F. Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care 30: 375–377, 2007. doi: 10.2337/dc06-1514.
15. Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, Fan S, Horowitz GL, Lim KH, Rana S, Takoudes TC, Wyckoff JA, Thadhani R, Karumanchi SA, Brown FM. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy 33: 81–92, 2014. doi: 10.3109/10641955.2013.837175.
16. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol 125: 5–12, 2015. doi: 10.1097/AOG.0000000000000564.
17. Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, Llurba E, Gratacós E. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors. Prenat Diagn 35: 183–191, 2015. doi: 10.1002/pd.4519.
18. Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Leszczynska-Gorzelak B, Oleszczuk J. Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 58: 39–45, 2007. doi: 10.1111/j. 1600-0897.2007.00489.x.
19. de Frutos T, de Miguel LS, García-Durán M, González-Fernández F, Rodríguez-Feo JA, Montón M, Guerra J, Farré J, Casado S, López-Farré A. NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-alpha. Am J Physiol Heart Circ Physiol 277: H1317–H1325, 1999.
20. Dowell FJ, Henrion D, Duriez M, Michel JB. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol 117: 341–346, 1996. doi: 10.1111/j.1476-5381.1996.tb15196.x.
21. Durst JK, Tuuli MG, Stout MJ, Macones GA, Cahill AG. Degree of obesity at delivery and risk of preeclampsia with severe features. Am J Obstet Gynecol 214: 651.e1–651.e5, 2016. doi: 10.1016/j.ajog.2015. 11.024.
22. Easmin S, Chowdhury TA, Islam MR, Beg A, Jahan MK, Latif T, Dhar S, Alam MN, Akhter M. Obstetric outcome in early and late onset gestational diabetes mellitus. Mymensingh Med J 24: 450–456, 2015.
23. Faas MM, Spaans F, De Vos P. Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol 5: 298, 2014. doi: 10.3389/ fimmu.2014.00298.
24. Farley D, Tejero ME, Comuzzie AG, Higgins PB, Cox L, Werner SL, Jenkins SL, Li C, Choi J, Dick EJ Jr, Hubbard GB, Frost P, Dudley DJ, Ballesteros B, Wu G, Nathanielsz PW, Schlabritz-Loutsevitch NE. Feto-placental adaptations to maternal obesity in the baboon. Placenta 30: 752–760, 2009. doi: 10.1016/j.placenta.2009.06.007.
25. Farley DM, Choi J, Dudley DJ, Li C, Jenkins SL, Myatt L, Nathanielsz PW. Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta 31: 718–724, 2010. doi: 10.1016/j.placenta.2010.06.006.
26. Frias AE, Morgan TK, Evans AE, Rasanen J, Oh KY, Thornburg KL, Grove KL. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 152: 2456–2464, 2011. doi: 10.1210/en. 2010-1332.
27. Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women. J Am Soc Hypertens 7: 137–148, 2013. doi: 10.1016/j.jash.2012.12.006.
28. Giacobbe A, Granese R, Grasso R, Salpietro V, Corrado F, Giorgianni G, Foti G, Amadore D, Triolo O, Giunta L, Di Benedetto A. Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus. Nutr Metab Cardiovasc Dis 26: 414–418, 2016. doi: 10.1016/j.numecd.2016.02.007.
29. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119: 1661–1670, 2009. doi: 10.1161/CIRCULATIONAHA.108.821181.
30. Guzmán-Gutiérrez E, Armella A, Toledo F, Pardo F, Leiva A, Sobrevia L. Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium. Purinergic Signal 12: 175–190, 2016. doi: 10.1007/ s11302-015-9491-2.
31. Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya F, Frühbeck G, Fernández-Real JM, Malagón MM. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in-cells. Int J Obes (Lond) 38: 1545–1554, 2014. doi: 10.1038/ijo.2014.36.
32. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, Varner MW, Wapner RJ, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Tolosa JE, Saade G, Sorokin Y, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol 204: 327.e1–327.e6, 2011. doi: 10.1016/j.ajog. 2011.02.024.
33. Hayward CE, Cowley EJ, Mills TA, Sibley CP, Wareing M. Maternal obesity impairs specific regulatory pathways in human myometrial arteries. Biol Reprod 90: 65, 2014. doi: 10.1095/biolreprod.113.112623.
34. Hayward CE, Higgins L, Cowley EJ, Greenwood SL, Mills TA, Sibley CP, Wareing M. Chorionic plate arterial function is altered in maternal obesity. Placenta 34: 281–287, 2013. doi: 10.1016/j.placenta.2013.01.001.
35. Hemmeryckx B, van Bree R, Van Hoef B, Vercruysse L, Lijnen HR, Verhaeghe J. Adverse adipose phenotype and hyperinsulinemia in gravid mice deficient in placental growth factor. Endocrinology 149: 2176–2183, 2008. doi: 10.1210/en.2007-1272.
36. Heude B, Thiébaugeorges O, Goua V, Forhan A, Kaminski M, Foliguet B, Schweitzer M, Magnin G, Charles MA; EDEN Mother-Child Cohort Study Group. Pre-pregnancy body mass index and weight gain during pregnancy: relations with gestational diabetes and hypertension, and birth outcomes. Matern Child Health J 16: 355–363, 2012. doi: 10.1007/s10995-011-0741-9.
37. Hildén K, Hanson U, Persson M, Fadl H. Overweight and obesity: a remaining problem in women treated for severe gestational diabetes. Diabet Med 33: 1045–1051, 2016. doi: 10.1111/dme.13156.
38. Huynh J, Xiong G, Bentley-Lewis R. A systematic review of metabolite profiling in gestational diabetes mellitus. Diabetologia 57: 2453–2464, 2014. doi: 10.1007/s00125-014-3371-0.
39. Huynh J, Yamada J, Beauharnais C, Wenger JB, Thadhani RI, Wexler D, Roberts DJ, Bentley-Lewis R. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta 36: 1161–1166, 2015. doi: 10. 1016/j.placenta.2015.08.004.
40. Hytten FE. Physiological changes in early pregnancy. J Obstet Gynaecol Br Commonw 75: 1193–1197, 1968. doi: 10.1111/j.1471-0528.1968.tb02915.x.
41. Ishihara G, Hiramatsu Y, Masuyama H, Kudo T. Streptozotocininduced diabetic pregnant rats exhibit signs and symptoms mimicking preeclampsia. Metabolism 49: 853–857, 2000. doi: 10.1053/meta.2000. 6750.
42. Jarmuzek P, Wielgos M, Bomba-Opon D. Placental pathologic changes in gestational diabetes mellitus. Neuro Endocrinol Lett 36: 101–105, 2015.
43. Jiang R, Cai J, Zhu Z, Chen D, Wang J, Wang Q, Teng Y, Huang Y, Tao M, Xia A, Xue M, Zhou S, Chen AF. Hypoxic trophoblast HMGB1 induces endothelial cell hyperpermeability via the TRL-4/caveolin-1 pathway. J Immunol 193: 5000–5012, 2014. doi: 10.4049/jimmunol.1303445.
44. Kim DW, Young SL, Grattan DR, Jasoni CL. Obesity during pregnancy disrupts placental morphology, cell proliferation, and inflammation in a sex-specific manner across gestation in the mouse. Biol Reprod 90: 130, 2014. doi: 10.1095/biolreprod.113.117259.
45. Kingdom JC, Drewlo S. Is heparin a placental anticoagulant in high-risk pregnancies? Blood 118: 4780–4788, 2011. doi: 10.1182/blood-2011-07-319749.
46. Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 37: 670–676, 2001. doi: 10.1161/01.HYP.37.2.670.
47. Lappas M. Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes. Metabolism 63: 860–873, 2014. doi: 10.1016/j.metabol.2014.03.007.
48. Lawlor DA, West J, Fairley L, Nelson SM, Bhopal RS, Tuffnell D, Freeman DJ, Wright J, Whitelaw DC, Sattar N. Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a prospective pregnancy cohort. Diabetologia 57: 2492–2500, 2014. doi: 10.1007/s00125-014-3386-6.
49. Leon-Garcia SM, Roeder HA, Nelson KK, Liao X, Pizzo DP, Laurent LC, Parast MM, LaCoursiere DY. Maternal obesity and sex-specific differences in placental pathology. Placenta 38: 33–40, 2016. doi: 10.1016/j.placenta.2015.12.006.
50. Li HP, Chen X, Li MQ. Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta. Int J Clin Exp Pathol 6: 650–659, 2013.
51. Li J, Ying H, Cai G, Guo Q, Chen L. Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre-eclampsia, as a cause for gestational diabetes mellitus. Cell Prolif 48: 166–174, 2015. doi: 10.1111/cpr.12164.
52. Li M, Song L, Gao X, Chang W, Qin X. Toll-like receptor 4 on islet cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes. Exp Mol Med 44: 260–267, 2012. doi: 10.3858/emm.2012.44.4.021.
53. Li N, Liu E, Guo J, Pan L, Li B, Wang P, Liu J, Wang Y, Liu G, Baccarelli AA, Hou L, Hu G. Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLoS One 8: e82310, 2013. doi: 10.1371/journal.pone.0082310.
54. Lin LT, Tsui KH, Cheng JT, Cheng JS, Huang WC, Liou WS, Tang PL. Increased risk of intracranial hemorrhage in patients with pregnancy-induced hypertension: a nationwide population-based retrospective cohort study. Medicine (Baltimore) 95: e3732, 2016. doi: 10.1097/ MD.0000000000003732.
55. Loardi C, Falchetti M, Prefumo F, Facchetti F, Frusca T. Placental morphology in pregnancies associated with pregravid obesity. J Matern Fetal Neonatal Med 29: 2611–2616, 2016. doi: 10.3109/14767058. 2015.1094792.
56. Loukovaara M, Leinonen P, Teramo K, Andersson S. Concentration of cord serum placenta growth factor in normal and diabetic pregnancies. BJOG 112: 75–79, 2005. doi: 10.1111/j.1471-0528.2004.00337.x.
57. Mandala M, Gokina N, Barron C, Osol G. Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats. J Vasc Res 49: 43–49, 2012. doi: 10.1159/000329821.
58. Marchetti T, de Moerloose P, Gris JC. Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study. J Thromb Haemost 14: 675–684, 2016. doi: 10.1111/jth.13257.
59. Margaritis M, Antonopoulos AS, Digby J, Lee R, Reilly S, Coutinho P, Shirodaria C, Sayeed R, Petrou M, De Silva R, Jalilzadeh S, Demosthenous M, Bakogiannis C, Tousoulis D, Stefanadis C, Choudhury RP, Casadei B, Channon KM, Antoniades C. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 127: 2209–2221, 2013. doi: 10.1161/ CIRCULATIONAHA.112.001133.
60. Martino J, Sebert S, Segura MT, García-Valdés L, Florido J, Padilla MC, Marcos A, Rueda R, McArdle HJ, Budge H, Symonds ME, Campoy C. Maternal body weight and gestational diabetes differentially influence placental and pregnancy outcomes. J Clin Endocrinol Metab 101: 59–68, 2016. doi: 10.1210/jc.2015-2590.
61. Masuyama H, Hiramatsu Y. Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice. Am J Physiol Endocrinol Metab 303: E293–E300, 2012. doi: 10.1152/ajpendo.00167.2012.
62. Masuyama H, Mitsui T, Maki J, Tani K, Nakamura K, Hiramatsu Y. Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high-fat diet-fed pregnant mice via constitutive androstane receptor. Mol Cell Biochem 419: 185–192, 2016. doi: 10.1007/s11010-016-2772-4.
63. Masuyama H, Nobumoto E, Segawa T, Hiramatsu Y. Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors. Acta Med Okayama 66: 171–175, 2012.
64. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F, Dong Z, Yoon BH, Hassan SS, Kusanovic JP. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med 37: 637–650, 2009. doi: 10.1515/ JPM.2009.101.
65. Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Erez O, Gotsch F, Chaiworapongsa T, Than NG, Kim SK, Nhan-Chang CL, Jodicke C, Pacora P, Yeo L, Dong Z, Yoon BH, Hassan SS, Mittal P. Maternal serum adiponectin multimers in preeclampsia. J Perinat Med 37: 349-363, 2009. doi: 10.1515/JPM.2009.085.
66. McDonald SD, Han Z, Mulla S, Beyene J; Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 341: c3428, 2010. doi: 10.1136/bmj.c3428.
67. Myatt L, Maloyan A. Obesity and placental function. Semin Reprod Med 34: 42–49, 2016. doi: 10.1055/s-0035-1570027.
68. Nerenberg KA, Johnson JA, Leung B, Savu A, Ryan EA, Chik CL, Kaul P. Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women. J Obstet Gynaecol Can 35: 986–994, 2013. doi: 10.1016/S1701-2163 (15) 30786-6.
69. Palei AC, Spradley FT, Granger JP. Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 308: R855–R861, 2015. doi: 10.1152/ajpregu. 00286.2014.
70. Pardo F, Silva L, Sáez T, Salsoso R, Gutiérrez J, Sanhueza C, Leiva A, Sobrevia L. Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond) 39: 1264–1273, 2015. doi: 10.1038/ijo.2015.57.
71. Persson M, Cnattingius S, Wikström AK, Johansson S. Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes. Diabetologia 59: 2099–2105, 2016. doi: 10.1007/s00125-016-4035-z.
72. Persson M, Cnattingius S, Wikström AK, Johansson S. Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes. Diabetologia 59: 2099–2105, 2016. doi: 10.1007/s00125-016-4035-z.
73. Popova P, Tkachuk A, Dronova A, Gerasimov A, Kravchuk E, Bolshakova M, Rozdestvenskaya O, Demidova K, Nikolaeva A, Grineva E. Fasting glycemia at the first prenatal visit and pregnancy outcomes in Russian women. Minerva Endocrinol 41: 477–485, 2016.
74. Powe CE, Allard C, Battista MC, Doyon M, Bouchard L, Ecker JL, Perron P, Florez JC, Thadhani R, Hivert MF. Heterogeneous contribution of insulin sensitivity and secretion defects to gestational diabetes mellitus. Diabetes Care 39: 1052–1055, 2016. doi: 10.2337/dc15-2672.
75. Powers RW, Roberts JM, Plymire DA, Pucci D, Datwyler SA, Laird DM, Sogin DC, Jeyabalan A, Hubel CA, Gandley RE. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension 60: 239-246, 2012. doi: 10.1161/HYPERTENSIONAHA.112.191213.
76. Ramirez VI, Miller E, Meireles CL, Gelfond J, Krummel DA, Powell TL. Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers. BMJ Open Diabetes Res Care 2: e000010, 2014. doi: 10.1136/bmjdrc-2013-000010.
77. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 66: 497–506, 2011. doi: 10.1097/ OGX.0b013e3182331028.
78. Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia-two placental causes of preeclampsia? Placenta 35, Suppl: S20–S25, 2014. doi: 10.1016/j.placenta.2013.12.008.
79. Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation. Ultrasound Obstet Gynecol 32: 871–876, 2008. doi: 10.1002/uog.6126.
80. Shah TJ, Leik CE, Walsh SW. Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci 17: 116–124, 2010. doi: 10.1177/1933719109348252.
81. Shirasuna K, Seno K, Ohtsu A, Shiratsuki S, Ohkuchi A, Suzuki H, Matsubara S, Nagayama S, Iwata H, Kuwayama T. AGEs and HMGB1 increase inflammatory cytokine production from human placental cells, resulting in an enhancement of monocyte migration. Am J Reprod Immunol 75: 557–568, 2016. doi: 10.1111/aji.12506.
82. Shortliffe LM, Hammam O, Han X, Kouba E, Tsao PS, Wang B. Dietary fructose in pregnancy induces hyperglycemia, hypertension, and pathologic kidney and liver changes in a rodent model. Pregnancy Hypertens 5: 308–314, 2015.
83. Shukla J, Walsh SW. Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia. Reprod Sci 22: 300–307, 2015. doi: 10.1177/1933719114557899.
84. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol Regul Integr Comp Physiol 272: R441–R463, 1997.
85. Spradley FT, Palei AC, Granger JP. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol 309: R1326–R1343, 2015. doi: 10.1152/ajpregu.00178.2015.
86. Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 56: 1026-1034, 2010. doi: 10.1161/HYPERTENSIONAHA.110.157743.
87. Sun W, Cui B, Hong F, Xu Y. Establishment of ApoE-knockout mouse model of preeclampsia and relevant mechanisms. Exp Ther Med 12: 2634–2638, 2016.
88. Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med 374: 434–443, 2016. doi: 10.1056/NEJMoa1509819.
89. Tamayo T, Tamayo M, Rathmann W, Potthoff P. Prevalence of gestational diabetes and risk of complications before and after initiation of a general systematic two-step screening strategy in Germany (2012–2014). Diabetes Res Clin Pract 115: 1–8, 2016. doi: 10.1016/j.diabres.2016. 03.001.
90. Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension 43: 988–992, 2004. doi: 10.1161/01.HYP.0000124460. 67539.1d.
91. Tsiakkas A, Duvdevani N, Wright A, Wright D, Nicolaides KH. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 45: 591–598, 2015. doi: 10.1002/uog.14811.
92. Wallace K, Novotny S, Heath J, Moseley J, Martin JN Jr, Owens MY, LaMarca B. Hypertension in response to CD4 (+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol 303: R144-R149, 2012. doi: 10.1152/ajpregu.00049.2012.
93. Warrington JP, George EM, Palei AC, Spradley FT, Granger JP. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension 62: 666–673, 2013. doi: 10.1161/HYPERTENSIONAHA. 113.00588.
94. Westermeier F, Salomón C, Farías M, Arroyo P, Fuenzalida B, Sáez T, Salsoso R, Sanhueza C, Guzmán-Gutiérrez E, Pardo F, Leiva A, Sobrevia L. Insulin requires normal expression and signaling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium. FASEB J 29: 37–49, 2015. doi: 10.1096/fj.14-254219.
95. Wotherspoon AC, Young IS, McCance DR, Holmes VA. Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review. J Diabetes Complications 30: 958–966, 2016. doi: 10.1016/j.jdiacomp.2016.02.001.
96. Young OM, Twedt R, Catov JM. Pre-pregnancy maternal obesity and the risk of preterm preeclampsia in the American primigravida. Obesity (Silver Spring) 24: 1226–1229, 2016. doi: 10.1002/oby.21412.
97. Zeng X, Pang H, Li X, Luo S, Jin S, Li S. Impact of obesity on endometrial blood flow in women without polycystic ovarian syndrome during intracytoplasmic sperm injection. Reprod Biol Endocrinol 11: 57, 2013. doi: 10.1186/1477-7827-11-57.
98. Zera CA, Seely EW, Wilkins-Haug LE, Lim KH, Parry SI, McElrath TF. The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies. Am J Obstet Gynecol 211: 247.e1-247.e7, 2014. doi: 10.1016/j.ajog.2014.03.020.
99. Zhu L, Zhang Z, Zhang L, Shi Y, Qi J, Chang A, Gao J, Feng Y, Yang X. HMGB1-RAGE signaling pathway in severe preeclampsia. Placenta 36: 1148–1152, 2015. doi: 10.1016/j.placenta.2015.08.006.